Pyxis Oncology, Inc. (PYXS)

Technical Shares at $2.63 are trading ... this earnings release. Broader biotech peers showed mixed moves, with names like CRBP, HURA and KALA up... ... Broader biotech peers showed mixed moves, with names like CRBP, HURA and KALA up while BMEA was down. Momentum data flag ZNTL and FATE each down ab…

HC Wainwright also issued estimates for Pyxis Oncology’s Q3 2026 earnings at ($0.25) EPS, Q4 2026 earnings at ($0.23) EPS, FY2026 earnings at ($0.99) EPS, Q1 2027 earnings at ($0.19) EPS, Q2 2027 earnings at ($0.19) EPS, Q3 2027 earnings at ($0.19) EPS, Q4 2027 earnings at ($0.20) EPS, FY2027 earnin…

Pyxis Oncology remains in the spotlight as investors track late-stage biotech catalysts tied to its oncology pipeline and cash runway.

Pyxis Oncology reported a Q1 2026 net loss of $56.2 million, up from $36.8 million a year ago, while bolstering its balance sheet to $539.8 million in cash via a recent offering.

PYXIS TANKERS ($PXS) posted quarterly earnings results for Q1 2026 on Monday, May 18th. The company reported earnings of $0.23 per share, beating estimates of $0.17 by $0.06. The company also reported revenue of $9,980,000, missing estimates of $11,160,500 by $-1,180,500. ... You can see Quiver Quan…